TrialThe Journal of clinical investigation2017
Ibrutinib treatment improves T cell number and function in CLL patients.
Meixiao Long et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
255 papers cite itlatest 60 shown
this papertrialcites it